{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:09:47Z","timestamp":1787062187530,"version":"build-2736575974"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1176628"],"award-info":[{"award-number":["1176628"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00401-020-02191-1","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T01:01:31Z","timestamp":1595984491000},"page":"279-294","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Reduction of advanced tau-mediated memory deficits by the MAP kinase p38\u03b3"],"prefix":"10.1007","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5244-6897","authenticated-orcid":false,"given":"Arne","family":"Ittner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prita Riana","family":"Asih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda R. P.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Prikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefine","family":"Bertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristie","family":"Stefanoska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.","family":"Volkerling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazi D.","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Delerue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars M.","family":"Ittner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,29]]},"reference":[{"key":"2191_CR1","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/jama.2019.4782","volume":"322","author":"Z Arvanitakis","year":"2019","unstructured":"Arvanitakis Z, Shah RC, Bennett DA (2019) Diagnosis and management of dementia: review. JAMA 322:1589\u20131599. https:\/\/doi.org\/10.1001\/jama.2019.4782","journal-title":"JAMA"},{"key":"2191_CR2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrn2194","volume":"8","author":"C Ballatore","year":"2007","unstructured":"Ballatore C, Lee VM, Trojanowski JQ (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci 8:663\u2013672. https:\/\/doi.org\/10.1038\/nrn2194","journal-title":"Nat Rev Neurosci"},{"key":"2191_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41467-017-00618-0","volume":"8","author":"M Bi","year":"2017","unstructured":"Bi M, Gladbach A, van Eersel J, Ittner A, Przybyla M, van Hummel A et al (2017) Tau exacerbates excitotoxic brain damage in an animal model of stroke. Nat Commun 8:473. https:\/\/doi.org\/10.1038\/s41467-017-00618-0","journal-title":"Nat Commun"},{"key":"2191_CR4","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1124\/jpet.105.085142","volume":"314","author":"HS Chen","year":"2005","unstructured":"Chen HS, Lipton SA (2005) Pharmacological implications of two distinct mechanisms of interaction of memantine with N-methyl-d-aspartate-gated channels. J Pharmacol Exp Ther 314:961\u2013971. https:\/\/doi.org\/10.1124\/jpet.105.085142","journal-title":"J Pharmacol Exp Ther"},{"key":"2191_CR5","doi-asserted-by":"publisher","first-page":"23818","DOI":"10.1074\/jbc.M701078200","volume":"282","author":"IH Cheng","year":"2007","unstructured":"Cheng IH, Scearce-Levie K, Legleiter J, Palop JJ, Gerstein H, Bien-Ly N et al (2007) Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. J Biol Chem 282:23818\u201323828. https:\/\/doi.org\/10.1074\/jbc.M701078200","journal-title":"J Biol Chem"},{"key":"2191_CR6","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","volume":"14","author":"EE Congdon","year":"2018","unstructured":"Congdon EE, Sigurdsson EM (2018) Tau-targeting therapies for Alzheimer disease. Nat Rev Neurol 14:399\u2013415. https:\/\/doi.org\/10.1038\/s41582-018-0013-z","journal-title":"Nat Rev Neurol"},{"key":"2191_CR7","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.neulet.2004.05.107","volume":"367","author":"RA Del Vecchio","year":"2004","unstructured":"Del Vecchio RA, Gold LH, Novick SJ, Wong G, Hyde LA (2004) Increased seizure threshold and severity in young transgenic CRND8 mice. Neurosci Lett 367:164\u2013167. https:\/\/doi.org\/10.1016\/j.neulet.2004.05.107","journal-title":"Neurosci Lett"},{"key":"2191_CR8","doi-asserted-by":"publisher","DOI":"10.3791\/55765","author":"F Delerue","year":"2017","unstructured":"Delerue F, Ittner LM (2017) Generation of genetically modified mice through the microinjection of oocytes. J Vis Exp. https:\/\/doi.org\/10.3791\/55765","journal-title":"J Vis Exp"},{"key":"2191_CR9","doi-asserted-by":"publisher","first-page":"12887","DOI":"10.1523\/jneurosci.2107-13.2013","volume":"33","author":"SL DeVos","year":"2013","unstructured":"DeVos SL, Goncharoff DK, Chen G, Kebodeaux CS, Yamada K, Stewart FR et al (2013) Antisense reduction of tau in adult mice protects against seizures. J Neurosci 33:12887\u201312897. https:\/\/doi.org\/10.1523\/jneurosci.2107-13.2013","journal-title":"J Neurosci"},{"key":"2191_CR10","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.1523\/JNEUROSCI.22-09-03445.2002","volume":"22","author":"I Dewachter","year":"2002","unstructured":"Dewachter I, Reverse D, Caluwaerts N, Ris L, Kuiperi C, Van den Haute C et al (2002) Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice. J Neurosci 22:3445\u20133453","journal-title":"J Neurosci"},{"key":"2191_CR11","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3233\/JAD-132789","volume":"41","author":"NF Fitz","year":"2014","unstructured":"Fitz NF, Castranio EL, Carter AY, Kodali R, Lefterov I, Koldamova R (2014) Improvement of memory deficits and amyloid-beta clearance in aged APP23 mice treated with a combination of anti-amyloid-beta antibody and LXR agonist. J Alzheimer\u2019s Dis JAD 41:535\u2013549. https:\/\/doi.org\/10.3233\/JAD-132789","journal-title":"J Alzheimer\u2019s Dis JAD"},{"key":"2191_CR12","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.neurobiolaging.2009.03.002","volume":"32","author":"L Gasparini","year":"2011","unstructured":"Gasparini L, Crowther RA, Martin KR, Berg N, Coleman M, Goedert M et al (2011) Tau inclusions in retinal ganglion cells of human P301S tau transgenic mice: effects on axonal viability. Neurobiol Aging 32:419\u2013433. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2009.03.002","journal-title":"Neurobiol Aging"},{"key":"2191_CR13","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1002\/jgm.381","volume":"5","author":"CP Glover","year":"2003","unstructured":"Glover CP, Bienemann AS, Hopton M, Harding TC, Kew JN, Uney JB (2003) Long-term transgene expression can be mediated in the brain by adenoviral vectors when powerful neuron-specific promoters are used. J Gene Med 5:554\u2013559. https:\/\/doi.org\/10.1002\/jgm.381","journal-title":"J Gene Med"},{"key":"2191_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0014-5793(97)00483-3","volume":"409","author":"M Goedert","year":"1997","unstructured":"Goedert M, Hasegawa M, Jakes R, Lawler S, Cuenda A, Cohen P (1997) Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases. FEBS Lett 409:57\u201362","journal-title":"FEBS Lett"},{"key":"2191_CR15","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1111\/j.1476-5381.2011.01713.x","volume":"165","author":"J Gotz","year":"2012","unstructured":"Gotz J, Ittner A, Ittner LM (2012) Tau-targeted treatment strategies in Alzheimer's disease. Br J Pharmacol 165:1246\u20131259. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01713.x","journal-title":"Br J Pharmacol"},{"key":"2191_CR16","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nrn2420","volume":"9","author":"J Gotz","year":"2008","unstructured":"Gotz J, Ittner LM (2008) Animal models of Alzheimer's disease and frontotemporal dementia. Nat Rev Neurosci 9:532\u2013544. https:\/\/doi.org\/10.1038\/nrn2420","journal-title":"Nat Rev Neurosci"},{"key":"2191_CR17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8:101\u2013112","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2191_CR18","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1038\/npp.2015.47","volume":"40","author":"AE Harasta","year":"2015","unstructured":"Harasta AE, Power JM, von Jonquieres G, Karl T, Drucker DJ, Housley GD et al (2015) Septal glucagon-like peptide 1 receptor expression determines suppression of cocaine-induced behavior. Neuropsychopharmacology 40:1969\u20131978. https:\/\/doi.org\/10.1038\/npp.2015.47","journal-title":"Neuropsychopharmacology"},{"key":"2191_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40478-015-0204-4","volume":"3","author":"K Hochgrafe","year":"2015","unstructured":"Hochgrafe K, Sydow A, Matenia D, Cadinu D, Konen S, Petrova O et al (2015) Preventive methylene blue treatment preserves cognition in mice expressing full-length pro-aggregant human Tau. Acta Neuropathol Commun 3:25. https:\/\/doi.org\/10.1186\/s40478-015-0204-4","journal-title":"Acta Neuropathol Commun"},{"key":"2191_CR20","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1056\/NEJMoa1106668","volume":"366","author":"R Howard","year":"2012","unstructured":"Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R et al (2012) Donepezil and memantine for moderate-to-severe Alzheimer's disease. N Engl J Med 366:893\u2013903. https:\/\/doi.org\/10.1056\/NEJMoa1106668","journal-title":"N Engl J Med"},{"key":"2191_CR21","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fnins.2020.00286","volume":"14","author":"M Iba","year":"2020","unstructured":"Iba M, Kim C, Florio J, Mante M, Adame A, Rockenstein E et al (2020) Role of alterations in protein kinase p38gamma in the pathogenesis of the synaptic pathology in dementia with lewy bodies and alpha-synuclein transgenic models. Front Neurosci 14:286. https:\/\/doi.org\/10.3389\/fnins.2020.00286","journal-title":"Front Neurosci"},{"key":"2191_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrneurol.2015.225","volume":"12","author":"K Iqbal","year":"2016","unstructured":"Iqbal K, Liu F, Gong CX (2016) Tau and neurodegenerative disease: the story so far. Nat Rev Neurol 12:15\u201327. https:\/\/doi.org\/10.1038\/nrneurol.2015.225","journal-title":"Nat Rev Neurol"},{"key":"2191_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/jnc.12821","volume":"132","author":"A Ittner","year":"2015","unstructured":"Ittner A, Bertz J, Suh LS, Stevens CH, Gotz J, Ittner LM (2015) Tau-targeting passive immunization modulates aspects of pathology in tau transgenic mice. J Neurochem 132:135\u2013145. https:\/\/doi.org\/10.1111\/jnc.12821","journal-title":"J Neurochem"},{"key":"2191_CR24","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1084\/jem.20120677","volume":"209","author":"A Ittner","year":"2012","unstructured":"Ittner A, Block H, Reichel CA, Varjosalo M, Gehart H, Sumara G et al (2012) Regulation of PTEN activity by p38delta-PKD1 signaling in neutrophils confers inflammatory responses in the lung. J Exp Med 209:2229\u20132246. https:\/\/doi.org\/10.1084\/jem.20120677","journal-title":"J Exp Med"},{"key":"2191_CR25","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1126\/science.aah6205","volume":"354","author":"A Ittner","year":"2016","unstructured":"Ittner A, Chua SW, Bertz J, Volkerling A, van der Hoven J, Gladbach A et al (2016) Site-specific phosphorylation of tau inhibits amyloid-beta toxicity in Alzheimer's mice. Science 354:904\u2013908. https:\/\/doi.org\/10.1126\/science.aah6205","journal-title":"Science"},{"key":"2191_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuron.2018.06.003","volume":"99","author":"A Ittner","year":"2018","unstructured":"Ittner A, Ittner LM (2018) Dendritic tau in Alzheimer's disease. Neuron 99:13\u201327. https:\/\/doi.org\/10.1016\/j.neuron.2018.06.003","journal-title":"Neuron"},{"key":"2191_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrn2967","volume":"12","author":"LM Ittner","year":"2011","unstructured":"Ittner LM, Gotz J (2011) Amyloid-beta and tau\u2014a toxic pas de deux in Alzheimer's disease. Nat Rev Neurosci 12:65\u201372. https:\/\/doi.org\/10.1038\/nrn2967","journal-title":"Nat Rev Neurosci"},{"key":"2191_CR28","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","volume":"142","author":"LM Ittner","year":"2010","unstructured":"Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J et al (2010) Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 142:387\u2013397. https:\/\/doi.org\/10.1016\/j.cell.2010.06.036","journal-title":"Cell"},{"key":"2191_CR29","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3389\/fnmol.2016.00116","volume":"9","author":"KL Jackson","year":"2016","unstructured":"Jackson KL, Dayton RD, Deverman BE, Klein RL (2016) Better targeting, better efficiency for wide-scale neuronal transduction with the synapsin promoter and AAV-PHP.B. Front Mol Neurosci 9:116. https:\/\/doi.org\/10.3389\/fnmol.2016.00116","journal-title":"Front Mol Neurosci"},{"key":"2191_CR30","doi-asserted-by":"publisher","first-page":"821","DOI":"10.2174\/1567205016666190228122218","volume":"16","author":"M Kaniakova","year":"2019","unstructured":"Kaniakova M, Nepovimova E, Kleteckova L, Skrenkova K, Holubova K, Chrienova Z et al (2019) Combination of memantine and 6-chlorotacrine as novel multi-target compound against Alzheimer's disease. Curr Alzheimer Res 16:821\u2013833. https:\/\/doi.org\/10.2174\/1567205016666190228122218","journal-title":"Curr Alzheimer Res"},{"key":"2191_CR31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0197-4580(02)00098-2","volume":"24","author":"PH Kelly","year":"2003","unstructured":"Kelly PH, Bondolfi L, Hunziker D, Schlecht HP, Carver K, Maguire E et al (2003) Progressive age-related impairment of cognitive behavior in APP23 transgenic mice. Neurobiol Aging 24:365\u2013378","journal-title":"Neurobiol Aging"},{"key":"2191_CR32","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/ejn.12126","volume":"37","author":"JY Kim","year":"2013","unstructured":"Kim JY, Ash RT, Ceballos-Diaz C, Levites Y, Golde TE, Smirnakis SM et al (2013) Viral transduction of the neonatal brain delivers controllable genetic mosaicism for visualising and manipulating neuronal circuits in vivo. Eur J Neurosci 37:1203\u20131220. https:\/\/doi.org\/10.1111\/ejn.12126","journal-title":"Eur J Neurosci"},{"key":"2191_CR33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/sj.gt.3301905","volume":"10","author":"S Kugler","year":"2003","unstructured":"Kugler S, Kilic E, Bahr M (2003) Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area. Gene Ther 10:337\u2013347. https:\/\/doi.org\/10.1038\/sj.gt.3301905","journal-title":"Gene Ther"},{"key":"2191_CR34","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/s0896-6273(03)00787-6","volume":"40","author":"MA Leissring","year":"2003","unstructured":"Leissring MA, Farris W, Chang AY, Walsh DM, Wu X, Sun X et al (2003) Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40:1087\u20131093. https:\/\/doi.org\/10.1016\/s0896-6273(03)00787-6","journal-title":"Neuron"},{"key":"2191_CR35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.nlm.2016.07.001","volume":"135","author":"A Masuda","year":"2016","unstructured":"Masuda A, Kobayashi Y, Kogo N, Saito T, Saido TC, Itohara S (2016) Cognitive deficits in single App knock-in mouse models. Neurobiol Learn Mem 135:73\u201382. https:\/\/doi.org\/10.1016\/j.nlm.2016.07.001","journal-title":"Neurobiol Learn Mem"},{"key":"2191_CR36","doi-asserted-by":"publisher","first-page":"e0123289","DOI":"10.1371\/journal.pone.0123289","volume":"10","author":"S Matsunaga","year":"2015","unstructured":"Matsunaga S, Kishi T, Iwata N (2015) Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis. PLoS ONE 10:e0123289. https:\/\/doi.org\/10.1371\/journal.pone.0123289","journal-title":"PLoS ONE"},{"key":"2191_CR37","doi-asserted-by":"publisher","first-page":"32040","DOI":"10.1074\/jbc.M112.401240","volume":"287","author":"S Mondragon-Rodriguez","year":"2012","unstructured":"Mondragon-Rodriguez S, Trillaud-Doppia E, Dudilot A, Bourgeois C, Lauzon M, Leclerc N et al (2012) Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-d-aspartate receptor-dependent tau phosphorylation. J Biol Chem 287:32040\u201332053. https:\/\/doi.org\/10.1074\/jbc.M112.401240","journal-title":"J Biol Chem"},{"key":"2191_CR38","doi-asserted-by":"publisher","first-page":"a006338","DOI":"10.1101\/cshperspect.a006338","volume":"2","author":"L Mucke","year":"2012","unstructured":"Mucke L, Selkoe DJ (2012) Neurotoxicity of amyloid beta-protein: synaptic and network dysfunction. Cold Spring Harbor Perspect Med 2:a006338. https:\/\/doi.org\/10.1101\/cshperspect.a006338","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"2191_CR39","doi-asserted-by":"publisher","first-page":"49694","DOI":"10.1074\/jbc.M405527200","volume":"279","author":"M Necula","year":"2004","unstructured":"Necula M, Kuret J (2004) Pseudophosphorylation and glycation of tau protein enhance but do not trigger fibrillization in vitro. J Biol Chem 279:49694\u201349703. https:\/\/doi.org\/10.1074\/jbc.M405527200","journal-title":"J Biol Chem"},{"key":"2191_CR40","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41582-018-0116-6","volume":"15","author":"F Panza","year":"2019","unstructured":"Panza F, Lozupone M, Logroscino G, Imbimbo BP (2019) A critical appraisal of amyloid-beta-targeting therapies for Alzheimer disease. Nat Rev Neurol 15:73\u201388. https:\/\/doi.org\/10.1038\/s41582-018-0116-6","journal-title":"Nat Rev Neurol"},{"key":"2191_CR41","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.neuropharm.2007.07.013","volume":"53","author":"CG Parsons","year":"2007","unstructured":"Parsons CG, Stoffler A, Danysz W (2007) Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system\u2013too little activation is bad, too much is even worse. Neuropharmacology 53:699\u2013723. https:\/\/doi.org\/10.1016\/j.neuropharm.2007.07.013","journal-title":"Neuropharmacology"},{"key":"2191_CR42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.febslet.2005.11.059","volume":"580","author":"JJ Pei","year":"2006","unstructured":"Pei JJ, An WL, Zhou XW, Nishimura T, Norberg J, Benedikz E et al (2006) P70 S6 kinase mediates tau phosphorylation and synthesis. FEBS Lett 580:107\u2013114. https:\/\/doi.org\/10.1016\/j.febslet.2005.11.059","journal-title":"FEBS Lett"},{"key":"2191_CR43","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/sj.emboj.7601587","volume":"26","author":"E Perdiguero","year":"2007","unstructured":"Perdiguero E, Ruiz-Bonilla V, Gresh L, Hui L, Ballestar E, Sousa-Victor P et al (2007) Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38alpha in abrogating myoblast proliferation. EMBO J 26:1245\u20131256. https:\/\/doi.org\/10.1038\/sj.emboj.7601587","journal-title":"EMBO J"},{"key":"2191_CR44","doi-asserted-by":"publisher","first-page":"e7934","DOI":"10.1371\/journal.pone.0007934","volume":"4","author":"AR Pogozelski","year":"2009","unstructured":"Pogozelski AR, Geng T, Li P, Yin X, Lira VA, Zhang M et al (2009) p38gamma mitogen-activated protein kinase is a key regulator in skeletal muscle metabolic adaptation in mice. PLoS ONE 4:e7934. https:\/\/doi.org\/10.1371\/journal.pone.0007934","journal-title":"PLoS ONE"},{"key":"2191_CR45","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s004010051148","volume":"99","author":"A Probst","year":"2000","unstructured":"Probst A, Gotz J, Wiederhold KH, Tolnay M, Mistl C, Jaton AL et al (2000) Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol 99:469\u2013481","journal-title":"Acta Neuropathol"},{"key":"2191_CR46","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F (2013) Genome engineering using the CRISPR-Cas9 system. Nat Protoc 8:2281\u20132308. https:\/\/doi.org\/10.1038\/nprot.2013.143","journal-title":"Nat Protoc"},{"key":"2191_CR47","doi-asserted-by":"publisher","first-page":"520289","DOI":"10.1155\/2012\/520289","volume":"2012","author":"A Risco","year":"2012","unstructured":"Risco A, Cuenda A (2012) New Insights into the p38gamma and p38delta MAPK Pathways. J Signal Transduct 2012:520289. https:\/\/doi.org\/10.1155\/2012\/520289","journal-title":"J Signal Transduct"},{"key":"2191_CR48","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1523\/JNEUROSCI.4152-10.2011","volume":"31","author":"ED Roberson","year":"2011","unstructured":"Roberson ED, Halabisky B, Yoo JW, Yao J, Chin J, Yan F et al (2011) Amyloid-beta\/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease. J Neurosci 31:700\u2013711. https:\/\/doi.org\/10.1523\/JNEUROSCI.4152-10.2011","journal-title":"J Neurosci"},{"key":"2191_CR49","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1126\/science.1141736","volume":"316","author":"ED Roberson","year":"2007","unstructured":"Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T et al (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316:750\u2013754. https:\/\/doi.org\/10.1126\/science.1141736","journal-title":"Science"},{"key":"2191_CR50","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1242\/jcs.066514","volume":"123","author":"G Sabio","year":"2010","unstructured":"Sabio G, Cerezo-Guisado MI, Del Reino P, Inesta-Vaquera FA, Rousseau S, Arthur JS et al (2010) p38gamma regulates interaction of nuclear PSF and RNA with the tumour-suppressor hDlg in response to osmotic shock. J Cell Sci 123:2596\u20132604. https:\/\/doi.org\/10.1242\/jcs.066514","journal-title":"J Cell Sci"},{"key":"2191_CR51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1042\/BJ20031628","volume":"380","author":"G Sabio","year":"2004","unstructured":"Sabio G, Reuver S, Feijoo C, Hasegawa M, Thomas GM, Centeno F et al (2004) Stress- and mitogen-induced phosphorylation of the synapse-associated protein SAP90\/PSD-95 by activation of SAPK3\/p38gamma and ERK1\/ERK2. Biochem J 380:19\u201330. https:\/\/doi.org\/10.1042\/BJ20031628","journal-title":"Biochem J"},{"key":"2191_CR52","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nn.3697","volume":"17","author":"T Saito","year":"2014","unstructured":"Saito T, Matsuba Y, Mihira N, Takano J, Nilsson P, Itohara S et al (2014) Single App knock-in mouse models of Alzheimer's disease. Nat Neurosci 17:661\u2013663. https:\/\/doi.org\/10.1038\/nn.3697","journal-title":"Nat Neurosci"},{"key":"2191_CR53","doi-asserted-by":"publisher","first-page":"e0210864","DOI":"10.1371\/journal.pone.0210864","volume":"14","author":"CL Sayas","year":"2019","unstructured":"Sayas CL, Medina M, Cuadros R, Olla I, Garcia E, Perez M et al (2019) Role of tau N-terminal motif in the secretion of human tau by End Binding proteins. PLoS ONE 14:e0210864. https:\/\/doi.org\/10.1371\/journal.pone.0210864","journal-title":"PLoS ONE"},{"key":"2191_CR54","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","volume":"388","author":"P Scheltens","year":"2016","unstructured":"Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S et al (2016) Alzheimer's disease. Lancet 388:505\u2013517. https:\/\/doi.org\/10.1016\/S0140-6736(15)01124-1","journal-title":"Lancet"},{"key":"2191_CR55","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1474-4422(13)70090-5","volume":"12","author":"MG Spillantini","year":"2013","unstructured":"Spillantini MG, Goedert M (2013) Tau pathology and neurodegeneration. Lancet Neurol 12:609\u2013622. https:\/\/doi.org\/10.1016\/S1474-4422(13)70090-5","journal-title":"Lancet Neurol"},{"key":"2191_CR56","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.001784","author":"K Stefanoska","year":"2018","unstructured":"Stefanoska K, Volkerling A, Bertz J, Poljak A, Ke YD, Ittner LM et al (2018) An N-terminal motif unique to primate tau enables differential protein-protein interactions. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.RA118.001784","journal-title":"J Biol Chem"},{"key":"2191_CR57","doi-asserted-by":"publisher","first-page":"13287","DOI":"10.1073\/pnas.94.24.13287","volume":"94","author":"C Sturchler-Pierrat","year":"1997","unstructured":"Sturchler-Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mistl C, Rothacher S et al (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci USA 94:13287\u201313292","journal-title":"Proc Natl Acad Sci USA"},{"key":"2191_CR58","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3233\/JAD-171058","volume":"62","author":"D Tan","year":"2018","unstructured":"Tan D, Yao S, Ittner A, Bertz J, Ke YD, Ittner LM et al (2018) Generation of a new tau knockout (tau \u0394ex1) line using CRISPR\/Cas9 genome editing in mice. J Alzheimer's Dis 62:571\u2013578","journal-title":"J Alzheimer's Dis"},{"key":"2191_CR59","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/82868","volume":"4","author":"KL Tucker","year":"2001","unstructured":"Tucker KL, Meyer M, Barde YA (2001) Neurotrophins are required for nerve growth during development. Nat Neurosci 4:29\u201337. https:\/\/doi.org\/10.1038\/82868","journal-title":"Nat Neurosci"},{"key":"2191_CR60","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1046\/j.1460-9568.2003.02444.x","volume":"17","author":"D Van Dam","year":"2003","unstructured":"Van Dam D, D'Hooge R, Staufenbiel M, Van Ginneken C, Van Meir F, De Deyn PP (2003) Age-dependent cognitive decline in the APP23 model precedes amyloid deposition. Eur J Neurosci 17:388\u2013396","journal-title":"Eur J Neurosci"},{"key":"2191_CR61","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/nan.12233","volume":"41","author":"J van Eersel","year":"2015","unstructured":"van Eersel J, Stevens CH, Przybyla M, Gladbach A, Stefanoska K, Chan CK et al (2015) Early-onset axonal pathology in a novel P301S-Tau transgenic mouse model of frontotemporal lobar degeneration. Neuropathol Appl Neurobiol 41:906\u2013925. https:\/\/doi.org\/10.1111\/nan.12233","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2191_CR62","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nprot.2006.116","volume":"1","author":"CV Vorhees","year":"2006","unstructured":"Vorhees CV, Williams MT (2006) Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc 1:848\u2013858. https:\/\/doi.org\/10.1038\/nprot.2006.116","journal-title":"Nat Protoc"},{"key":"2191_CR63","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1073\/pnas.1217832110","volume":"110","author":"DG Woolley","year":"2013","unstructured":"Woolley DG, Laeremans A, Gantois I, Mantini D, Vermaercke B, Op de Beeck HP et al (2013) Homologous involvement of striatum and prefrontal cortex in rodent and human water maze learning. Proc Natl Acad Sci USA 110:3131\u20133136. https:\/\/doi.org\/10.1073\/pnas.1217832110","journal-title":"Proc Natl Acad Sci USA"},{"key":"2191_CR64","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/sj.gt.3301529","volume":"8","author":"R Xu","year":"2001","unstructured":"Xu R, Janson CG, Mastakov M, Lawlor P, Young D, Mouravlev A et al (2001) Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes. Gene Ther 8:1323\u20131332. https:\/\/doi.org\/10.1038\/sj.gt.3301529","journal-title":"Gene Ther"},{"key":"2191_CR65","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1038\/nprot.2014.134","volume":"9","author":"H Yang","year":"2014","unstructured":"Yang H, Wang H, Jaenisch R (2014) Generating genetically modified mice using CRISPR\/Cas-mediated genome engineering. Nat Protoc 9:1956\u20131968. https:\/\/doi.org\/10.1038\/nprot.2014.134","journal-title":"Nat Protoc"},{"key":"2191_CR66","doi-asserted-by":"publisher","first-page":"E88","DOI":"10.1093\/nar\/29.17.e88","volume":"29","author":"S Ye","year":"2001","unstructured":"Ye S, Dhillon S, Ke X, Collins AR, Day IN (2001) An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 29:E88\u201388","journal-title":"Nucleic Acids Res"},{"key":"2191_CR67","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/jnnp-2012-303144","volume":"84","author":"Y Yoshiyama","year":"2013","unstructured":"Yoshiyama Y, Lee VM, Trojanowski JQ (2013) Therapeutic strategies for tau mediated neurodegeneration. J Neurol Neurosurg Psychiatry 84:784\u2013795. https:\/\/doi.org\/10.1136\/jnnp-2012-303144","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-020-02191-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-020-02191-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-020-02191-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T19:26:41Z","timestamp":1627500401000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-020-02191-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,29]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["2191"],"URL":"https:\/\/doi.org\/10.1007\/s00401-020-02191-1","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,29]]},"assertion":[{"value":"5 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"AI and LMI are inventors on a patent application related to targeting p38\u03b3 and Thr-205 tau in Alzheimer\u2019s and other neurodegenerative diseases (Australian Patent Number APA#2016900764).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}